Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2026-11-12Psilocybin Recovery Intervention for Stopping Methamphetamine UseClinicalTrials.gov · 2026-11-09Psilocybin modulates nucleus accumbens activity via astrocytic transcriptional regulation.Experimental & molecular medicine · 2026-11-05Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-11-05Scn2a-deficient mice exhibit serotonergic dysfunction and altered behavioral responses to psilocybinbioRxiv · 2026-11-04Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary AnalysisJournal of Pain and Symptom Management · 2026-11-01α-Adrenergic receptor modulates 5-HT-mediated behavioral effects of MDMA and psilocybin in mice.Molecular psychiatry · 2026-11-01A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.ClinicalTrials.gov · 2026-10-29A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and DepressionClinicalTrials.gov · 2026-10-29Safety, Efficacy, and Mechanisms of Psilocybin-assisted Acceptance and Commitment Therapy (PACT) in Treating Major Depressive Disorder (MDD) Among VeteransClinicalTrials.gov · 2026-10-26A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-10-23A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-10-21Mystical experiences mediate the effects of psilocybin-assisted psychotherapy + mindfulness-based stress reduction on trait mindfulness and depression symptoms: mechanistic results from a randomized controlled trialJournal of Affective Disorders Reports · 2026-10-11Psilocybin-Assisted Therapy in Depressive Disorders: Clinical Governance, Safety, and Translational ChallengesResearchGate · 2026-10-05Study participant perceptions of the relevance of therapist and study team personal psychedelic experiencePsychedelics · 2026-10-03ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted TherapyClinicalTrials.gov · 2026-09-22Psilocybin in the Treatment of Methamphetamine Use DisorderClinicalTrials.gov · 2026-09-21Exploring the Therapeutic Potential of Psilocybin: A Comprehensive Review of Clinical Trial Evidence and Implications for Rescheduling.Mini reviews in medicinal chemistry · 2026-09-18Modulating the Thermodynamics and Kinetics of Psychedelics at Serotonin Receptors via Terahertz WavesThe Journal of Physical Chemistry B · 2026-09-12Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCDFrontiers in Psychiatry · 2026-09-08High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite TrialClinicalTrials.gov · 2026-09-02Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-09-02Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.Pharmacological research · 2026-09-01A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.Journal of psychopharmacology (Oxford, England) · 2026-08-29Aquahenosis: a non-pharmacological altered state of consciousness induced by floatation-REST in individuals with anxiety and depression.Neuroscience of consciousness · 2026-08-26The trials of translating psilocybin treatment from research to practice.Nature medicine · 2026-08-21Psychedelics align brain activity with context.Nature · 2026-08-19Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.Journal of psychopharmacology (Oxford, England) · 2026-08-17The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderClinicalTrials.gov · 2026-08-13A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic TherapyClinicalTrials.gov · 2026-08-06In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocinArchives of Toxicology · 2026-08-01Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.Hearing research · 2026-08-01Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depressionPharmacological Research · 2026-08-01A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.The International journal on drug policy · 2026-08-01Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from JamaicaFrontiers in Psychiatry · 2026-07-29Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled TrialClinicalTrials.gov · 2026-07-14Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Raman Activity Investigation and Utilization of PsilocybinJournal of Raman Spectroscopy · 2026-07-01Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-015-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderClinicalTrials.gov · 2026-06-29Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortexJournal of Psychopharmacology · 2026-06-28Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy SubjectsClinicalTrials.gov · 2026-06-25PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEWInternational Journal of Innovative Technologies in Social Science · 2026-06-24Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.The international journal of neuropsychopharmacology · 2026-06-02Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report.Cureus · 2026-06-01Psilocybin: Chemical Foundations and Emerging Therapeutic PotentialMini-Reviews in Medicinal Chemistry · 2026-06-01Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026-06-01Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-06-01Psilocybin-facilitated Treatment for Cocaine UseClinicalTrials.gov · 2026-05-18Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)ClinicalTrials.gov · 2026-05-14Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.PsyArXiv · 2026-05-14Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based SampleClinicalTrials.gov · 2026-05-12A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-ControlClinicalTrials.gov · 2026-05-04Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-05-01Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.Journal of psychopharmacology (Oxford, England) · 2026-05-01Psilocybin-Enhanced Psychotherapy for Methamphetamine Use DisorderClinicalTrials.gov · 2026-04-22Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted PsychotherapyClinicalTrials.gov · 2026-04-22Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin2026 IEEE 23rd International Symposium on Biomedical Imaging (ISBI) · 2026-04-08Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes.Neuroscience · 2026-04-06Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy ParticipantsClinicalTrials.gov · 2026-04-02Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews · 2026-04-01The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse modelProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-04-01Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military PersonnelJournal of Police and Criminal Psychology · 2026-03-22Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional HealthClinicalTrials.gov · 2026-03-11Psilocybin-facilitated Treatment for Chronic PainClinicalTrials.gov · 2026-03-11Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-03-01Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH StudyClinicalTrials.gov · 2026-02-17Psilocybin-Assisted Cognitive Behavioral Therapy for DepressionClinicalTrials.gov · 2026-02-12Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials.Neuropharmacology · 2026-02-01The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-25Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-RESTPsyArXiv · 2026-01-15Psilocybin for Treatment-Resistant OCD: A Randomized Controlled TrialPsyArXiv · 2026-01-15Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration modelNeuroscience Applied · 2026-01-01Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".Global advances in integrative medicine and health · 2026-01-01Behavioral and neuronal effects of psilocybin in miceNeuroscience Applied · 2026-01-01Metastability of resting-state bold fMRI as a reliable biomarker of individual brain dynamics: An interrogation of within-subject variability as a function of total acquisition time.Network neuroscience (Cambridge, Mass.) · 2026-01-01Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.Journal of clinical psychopharmacology · 2026-01-01Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.Journal of clinical medicine · 2025-12-29Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-19Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-12-09Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case ReportDOAJ (DOAJ: Directory of Open Access Journals) · 2025-12-01Psilocybin vs Ketamine for Alcohol Use DisorderClinicalTrials.gov · 2025-11-28Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of LifeClinicalTrials.gov · 2025-11-25Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-11-21Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy HumansClinicalTrials.gov · 2025-11-19Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use DisorderClinicalTrials.gov · 2025-11-17A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic CancerClinicalTrials.gov · 2025-11-05Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.EClinicalMedicine · 2025-11-01Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report.Palliative & supportive care · 2025-10-23Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping ReviewPreprints.org · 2025-10-17Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activationUNC Libraries · 2025-10-16A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic CancerClinicalTrials.gov · 2025-10-14A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From MethamphetamineClinicalTrials.gov · 2025-10-07Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg's Archives of Pharmacology · 2025-10-01The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Neuron · 2025-10-01Dynamic myocardial injury and variable hallucination latency in poisoning: a molecularly confirmed case series from China.Clinical toxicology (Philadelphia, Pa.) · 2025-10-01Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.Nature communications · 2025-09-30S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-19Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.PLoS medicine · 2025-09-01Psilocybin: Systematic review of its use in the treatment of depressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2025-08-26“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-25Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder AnalysisResearch Square · 2025-08-19Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.Cureus · 2025-08-01Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET StudyResearch Square · 2025-07-27The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)ClinicalTrials.gov · 2025-07-23The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.Neuroscience and biobehavioral reviews · 2025-07-015-HT receptors: Pharmacology and functional selectivity.Pharmacological reviews · 2025-07-01Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.Swiss medical weekly · 2025-07-01Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.Current oncology (Toronto, Ont.) · 2025-06-30Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autismMagna Scientia Advanced Research and Reviews · 2025-06-28Visual Surround Suppression and Perceptual Expectation Under PsilocybinClinicalTrials.gov · 2025-06-27The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-05-01Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.Journal of psychoactive drugs · 2025-04-25Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study).ClinicalTrials.gov · 2025-04-11The compulsive eating paradigm: can psychedelics help in treating obesity?Journal of eating disorders · 2025-04-07Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.Journal of child and adolescent psychopharmacology · 2025-04-01Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-04-01Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025-04-01Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.Progress in neuro-psychopharmacology & biological psychiatry · 2025-03-20Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachClinicalTrials.gov · 2025-03-19Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy SubjectsClinicalTrials.gov · 2025-03-05Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi.Journal of the American Society for Mass Spectrometry · 2025-03-05Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.Journal of psychoactive drugs · 2025-03-03A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)The international journal of neuropsychopharmacology · 2025-02-01What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?Cochrane Clinical Answers · 2025-01-13Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERSHealth and Society · 2025-01-08Molecular brain imaging of psychedelic action.International review of neurobiology · 2025-01-01"" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.Integrative cancer therapies · 2025-01-01Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.Neuroscience applied · 2025-01-01Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.General hospital psychiatry · 2025-01-01The many faces of psilocybin-related psychosis: A case seriesPsychiatry Research Case Reports · 2024-12-07Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.JAMA network open · 2024-12-02Impact of psilocybin on cognitive function: A systematic review.Psychiatry and clinical neurosciences · 2024-12-01Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)Current Psychology · 2024-11-21PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related BurnoutClinicalTrials.gov · 2024-11-12Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.Physiology & behavior · 2024-10-01Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.Journal of psychopharmacology (Oxford, England) · 2024-10-01Psilocybin legalization in the United States and psychological reactance: A test of evidence uncertainty, controlling language, and an ambiguous call to action.Motivation Science · 2024-09-23Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.The Cochrane database of systematic reviews · 2024-09-12A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-19A 24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)ClinicalTrials.gov · 2024-08-15Prevalence and Correlates of Psychedelic Use in Poland: A Study on a Representative Sample of Polish AdultsResearch Square · 2024-08-15The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.The Annals of pharmacotherapy · 2024-08-01Psilocybin desynchronizes the human brain.Nature · 2024-08-01Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse IndicationsDrug and Alcohol Dependence · 2024-07-01Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology · 2024-05-31Medical Uses and Adverse Effects of Psilocybin.The primary care companion for CNS disorders · 2024-05-28The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.Journal of psychopharmacology (Oxford, England) · 2024-05-01Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.Psychiatry research · 2024-05-01Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice.Journal of psychopharmacology (Oxford, England) · 2024-05-01Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over StudyClinicalTrials.gov · 2024-04-25Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.Cancer · 2024-04-01Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort.Brain sciences · 2024-03-31Five New Species of from Xizang Autonomous Region of China and Surrounding Areas.Journal of fungi (Basel, Switzerland) · 2024-03-18Psilocybin poisoning from Psilocybe argentipes ingestionVisual Journal of Emergency Medicine · 2024-03-11Psychedelika-assistierte PsychotherapieDie Psychotherapie · 2024-02-28Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol AddictionResearch Square · 2024-02-22Introduction to the Special Section on Psychedelics Research and TreatmentPerspectives in biology and medicine · 2024-01-01Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.Expert review of clinical pharmacology · 2024-01-01Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.The American journal of psychiatry · 2024-01-01The safety of supported psilocybin use in Oregon.Nature medicine · 2024-01-01Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.Frontiers in psychiatry · 2024-01-01On the mushrooming reports of "quiet quitting": Employees' lifetime psilocybin use predicts their overtime hours worked.Journal of psychoactive drugs · 2024-01-01A narrative exploration of psilocybin's potential in mental health.Frontiers in psychiatry · 2024-01-01Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.Dermatitis: contact, atopic, occupational, drug · 2024-01-01Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial.Canadian journal of pain = Revue canadienne de la douleur · 2024-01-01Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity.Chinese medical journal · 2023-12-20Managing expectations with psychedelic microdosingnpj Mental Health Research · 2023-11-08Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocolEuropean Journal of Trauma & Dissociation · 2023-10-25Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study IIClinicalTrials.gov · 2023-10-12The zebrafish for preclinical psilocybin research.Neuroscience and biobehavioral reviews · 2023-10-01Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced MeditatorsClinicalTrials.gov · 2023-09-21Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.Journal of pain and symptom management · 2023-09-01Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.Molecular psychiatry · 2023-09-01Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapyJournal of Psychedelic Studies · 2023-08-21An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients.ClinicalTrials.gov · 2023-07-25Trip Where you Stand: Towards Psychedelic LiberationFeminist Review · 2023-07-01Psychedelics reopen the social reward learning critical periodNature · 2023-06-13Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.World journal of psychiatry · 2023-05-19The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCDPsyArXiv · 2023-03-17Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signalingCNS Neuroscience & Therapeutics · 2023-03-01Psilocybin for Treatment-Resistant Depression.The New England journal of medicine · 2023-02-23Considerations in assessing the abuse potential of psychedelics during drug development.Neuropharmacology · 2023-02-15Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trialJournal of Psychedelic Studies · 2023-01-18Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeismJournal of Psychedelic Studies · 2023-01-16Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.Perspectives in biology and medicine · 2023-01-01Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Frontiers in psychiatry · 2023-01-01Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD.Journal of psychoactive drugs · 2023-01-01Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2023-01-01A Review of Synthetic Access to Therapeutic Compounds Extracted from.Pharmaceuticals (Basel, Switzerland) · 2022-12-28